US researchers have begun a groundbreaking trial to test the potential of umbilical cord blood transplants, a kind of stem cell therapy, to treat and possibly reverse hearing loss in infants.
Related posts:
Cuba says cholera cases rise to 158
New poppy blight poised to boost opium price: U.N.
Royals to visit Prince Philip after heart surgery
Sanofi to test Parkinson's drug with Michael J. Fox Foundation
Valeant says currency fluctuations hitting results
18 Million U.S. Cancer Survivors Expected by 2022: Report
Views: 0